Viviana Gianino

Title: Viviana Gianino: Innovator in Vaccine Development

Introduction

Viviana Gianino is a prominent inventor based in Catania, Italy. She has made significant contributions to the field of vaccine development, particularly in the area of combined vaccines. Her innovative work has the potential to impact public health positively.

Latest Patents

Viviana Gianino holds a patent for a combined measles-malaria vaccine. This vaccine contains different attenuated recombinant measles-malaria vectors that comprise a heterologous nucleic acid encoding several antigens. The invention relates to viral vectors that include nucleic acids encoding the circumsporozoite (CS) protein, the merozoite surface protein 1 (MSP-1), and its derivatives in both glycosylated and secreted forms, as well as the apical membrane antigen 1 (AMA1) in its anchored or secreted form. The viral vector is derived from an attenuated measles virus, which is efficient in delivering the gene of interest and effectively binds to and infects relevant immune cells.

Career Highlights

Viviana Gianino is associated with Cadila Healthcare Limited, where she continues her research and development efforts. Her work in vaccine innovation has garnered attention and recognition in the scientific community.

Collaborations

Some of her notable coworkers include Martin Billeter and Reinhard Glueck. Their collaborative efforts contribute to the advancement of vaccine technology and research.

Conclusion

Viviana Gianino's contributions to vaccine development, particularly her combined measles-malaria vaccine, highlight her role as an innovator in the field. Her work exemplifies the importance of research in improving global health outcomes.